DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 40 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,974,209 | +27.9% | 1,811,483 | +0.3% | 0.00% | – |
| Q1 2023 | $5,454,561 | +47.4% | 1,806,146 | +0.1% | 0.00% | – |
| Q4 2022 | $3,700,472 | -43.3% | 1,805,108 | -4.3% | 0.00% | – |
| Q3 2022 | $6,528,000 | -18.2% | 1,886,840 | -0.4% | 0.00% | – |
| Q2 2022 | $7,976,000 | +38.3% | 1,894,481 | -0.1% | 0.00% | – |
| Q1 2022 | $5,768,000 | +13.1% | 1,897,223 | +73.1% | 0.00% | – |
| Q4 2021 | $5,098,000 | -63.7% | 1,096,213 | -39.8% | 0.00% | – |
| Q3 2021 | $14,044,000 | -10.5% | 1,821,550 | -0.2% | 0.00% | – |
| Q2 2021 | $15,688,000 | -36.0% | 1,824,310 | -15.4% | 0.00% | -100.0% |
| Q1 2021 | $24,501,000 | – | 2,156,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $9,545,000 | 2.59% |
| Samsara BioCapital, LLC | 826,422 | $2,512,000 | 0.63% |
| Orbimed Advisors | 4,945,192 | $15,033,000 | 0.24% |
| Alphabet Inc. | 1,636,258 | $4,974,000 | 0.16% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,000,000 | 0.10% |
| Casdin Capital, LLC | 330,000 | $1,003,000 | 0.04% |
| Bronte Capital Management Pty Ltd. | 163,224 | $496,000 | 0.04% |
| MYDA Advisors LLC | 20,000 | $61,000 | 0.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $801,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $124,716,000 | 0.02% |